101 related articles for article (PubMed ID: 7146409)
1. Perfluoroctylbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast material.
Mattrey RF; Scheible FW; Gosink BB; Leopold GR; Long DM; Higgins CB
Radiology; 1982 Dec; 145(3):759-62. PubMed ID: 7146409
[TBL] [Abstract][Full Text] [Related]
2. Perfluoroctylbromide: a reticuloendothelial-specific and tumor-imaging agent for computed tomography.
Mattrey RF; Long DM; Multer F; Mitten R; Higgins CB
Radiology; 1982 Dec; 145(3):755-8. PubMed ID: 7146408
[TBL] [Abstract][Full Text] [Related]
3. Experimental comparison of EOE-13 and perfluoroctylbromide for the CT detection of hepatic metastases.
Patronas N; Miller DL; Girton M
Invest Radiol; 1984; 19(6):570-3. PubMed ID: 6096289
[TBL] [Abstract][Full Text] [Related]
4. Perfluorochemicals as liver- and spleen-seeking ultrasound contrast agents.
Mattrey RF; Leopold GR; vanSonnenberg E; Gosink BB; Scheible FW; Long DM
J Ultrasound Med; 1983 Apr; 2(4):173-6. PubMed ID: 6854723
[TBL] [Abstract][Full Text] [Related]
5. Potential role of PFOB enhanced sonography of the kidney. I. Detection of renal function and acute tubular necrosis.
Munzing D; Mattrey RF; Reznik VM; Mitten RM; Peterson T
Kidney Int; 1991 Apr; 39(4):733-9. PubMed ID: 2051731
[TBL] [Abstract][Full Text] [Related]
6. [Tumor imaging effects of perfluoroctylbromide (PFOB) emulsion].
Murata K; Itoh Y; Ayakawa Y; Miyata N
Nihon Gan Chiryo Gakkai Shi; 1988 Dec; 23(11):2669-78. PubMed ID: 3249107
[No Abstract] [Full Text] [Related]
7. Perfluoroctylbromide as a gastrointestinal contrast agent for MR imaging: use with and without glucagon.
Brown JJ; Duncan JR; Heiken JP; Balfe DM; Corr AP; Mirowitz SA; Eilenberg SS; Lee JK
Radiology; 1991 Nov; 181(2):455-60. PubMed ID: 1924788
[TBL] [Abstract][Full Text] [Related]
8. Ultrasonic contrast enhancement of tissue by encapsulated microbubbles.
Carroll BA; Young SW; Rasor JS; Briller RB; Cassel DM
Radiology; 1982 Jun; 143(3):747-50. PubMed ID: 7079504
[TBL] [Abstract][Full Text] [Related]
9. Specific enhancement of intra-abdominal abscesses with perfluoroctylbromide for CT imaging.
Mattrey RF; Andrè M; Campbell J; Mitten R; Multer F; Hackney D; Long DM; Higgins CB
Invest Radiol; 1984; 19(5):438-46. PubMed ID: 6511250
[TBL] [Abstract][Full Text] [Related]
10. [Sonography of experimental hypovascularized kidney tumors].
Baranyai T; Vargha G; Gyarmati J
Rofo; 1988 Dec; 149(6):654-9. PubMed ID: 2849166
[TBL] [Abstract][Full Text] [Related]
11. Potential role of PFOB enhanced sonography of the kidney. II. Detection of partial infarction.
Coley BD; Mattrey RF; Roberts A; Keane S
Kidney Int; 1991 Apr; 39(4):740-5. PubMed ID: 2051732
[TBL] [Abstract][Full Text] [Related]
12. [Imaging of tumor, liver and spleen with computed tomography (CT) using perfluoroctylbromide emulsion (PFOB)].
Murata K
Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):104-13. PubMed ID: 3379326
[No Abstract] [Full Text] [Related]
13. Detection of tumors with 19F magnetic resonance imaging.
Ratner AV; Muller HH; Bradley-Simpson B; Johnson DE; Hurd RE; Sotak C; Young SW
Invest Radiol; 1988 May; 23(5):361-4. PubMed ID: 3384616
[TBL] [Abstract][Full Text] [Related]
14. Perfluoroctylbromide as a blood pool contrast agent for liver, spleen, and vascular imaging in computed tomography.
Mattrey RF; Long DM; Peck WW; Slutsky RA; Higgins CB
J Comput Assist Tomogr; 1984 Aug; 8(4):739-44. PubMed ID: 6736376
[TBL] [Abstract][Full Text] [Related]
15. [Computed tomographic studies on density kinetics after the bolus injection and infusion of perfluorooctylbromide (PFOB). Animal experimental studies].
Adam G; Günther RW; Prescher A; Goertz H; Schiffer C; Bruchmüller K; Limmer J
Rofo; 1992 May; 156(5):487-91. PubMed ID: 1596555
[TBL] [Abstract][Full Text] [Related]
16. Detection of hepatic VX2 tumors in rabbits: comparison of conventional US and phase-inversion harmonic US during the liver-specific late phase of contrast enhancement.
Lee JM; Youk JH; Lee YH; Kim YK; Kim CS; Li CA
Korean J Radiol; 2003; 4(2):124-9. PubMed ID: 12845308
[TBL] [Abstract][Full Text] [Related]
17. Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery.
Li X; Sui Z; Li X; Xu W; Guo Q; Sun J; Jing F
Int J Nanomedicine; 2018; 13():3053-3067. PubMed ID: 29872293
[TBL] [Abstract][Full Text] [Related]
18. Assessment of liver and kidney enhancement with a perfluorocarbon vapor-stabilized US contrast agent.
Girard MS; Baker KG; Steinbach GC; Deiranieh LH; Peterson TM; Mattrey RF
Acad Radiol; 1999 May; 6(5):273-81. PubMed ID: 10228616
[TBL] [Abstract][Full Text] [Related]
19. B-mode enhancement of the liver with microbubble contrast agent: a blinded study in rabbits with VX2 tumors.
Girard MS; Kono Y; Sirlin CB; Baker KG; Deiranieh LH; Mattrey RF
Acad Radiol; 2001 Aug; 8(8):734-40. PubMed ID: 11508752
[TBL] [Abstract][Full Text] [Related]
20. Physical and acoustical properties of perfluorooctylbromide, an ultrasound contrast agent.
André M; Nelson T; Mattrey R
Invest Radiol; 1990 Sep; 25(9):983-7. PubMed ID: 2211056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
